DVA Risk Pregnancy
Launched by MEDICAL UNIVERSITY OF VIENNA · Jan 15, 2015
Trial Information
Current as of April 24, 2025
Unknown status
Keywords
ClinConnect Summary
No description provided
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • • Age \>18 years
- • Written informed consent
- • Pregnancy at screening
- • Normal ophthalmic findings, unless the investigator considers a finding clinically irrelevant.
- • Ametropy \<= 3,5 Dpt.
- For pregnant women with preeclampsia:
- • Systolic BP ≥140 mmHg, or diastolic BP ≥90 mmHg on at least 2 occasions AND
- • Proteinuria (≥300 mg/day) after 20 weeks of gestation in preeclampsia
- • Pregnant at the time of confirming diagnosis of preeclampsia
- For pregnant women with obesity:
- • • Pre-pregnancy BMI ≥30 as assessed from medical history
- According to the WHO BMI classification:
- • Underweight (less than 18.5)
- • normal weight (18.5-24.9)
- • overweight (25-29.9)
- • obese class I (30 -34.9)
- • obese class II (35-39.9)
- • obese class III (40 or more) For non-pregnant control subjects
- • Age \>18 years
- • Written informed consent
- • Not pregnant at screening
- • Normal ophthalmic and medical findings, unless the investigator considers a finding clinically irrelevant.
- • Ametropy \<= 3,5 Dpt.
- Exclusion Criteria:
- • Diabetes mellitus type I or II
- • Renal failure requiring dialysis
- • Cirrhosis of liver
- • Collagenosis
- • Vasculitis
- • Paraproteinaemia
- • Alcohol abuse
- • Amyloidosis
- • Clinical signs of polyneuropathy
- • Any other clinical finding, unless the clinical investigator considers a finding to be non clinically significant.
About Medical University Of Vienna
The Medical University of Vienna is a leading research institution dedicated to advancing healthcare through innovative clinical research and education. Renowned for its commitment to excellence in medical science, the university fosters interdisciplinary collaboration among researchers, clinicians, and academic professionals. Its clinical trials encompass a wide range of medical disciplines, aiming to develop cutting-edge therapies and improve patient outcomes. With state-of-the-art facilities and a strong emphasis on ethical standards, the Medical University of Vienna is at the forefront of transforming scientific discoveries into practical applications that enhance global health.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Vienna, , Austria
Vienna, , Austria
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials